Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma - a Nordic Lymphoma Group Trial

NCT00963534 is registered in ClinicalTrials.gov with Lund University Hospital as lead sponsor.

NCT NCT00963534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00963534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma - a Nordic Lymphoma Group Trial
Lead sponsor
Lund University Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 2009
Completion date
August 31, 2017
Enrollment
51 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

mantle cell lymphoma